| Forward Pharmaceutical Sciences |
| MEI Liankuo, WEI Qiangqiang, ZHANG Huibin and ZHOU Jinpei
Research progress in acetyl-CoA carboxylase inhibitors
2019,50(3):253. [摘要] [PDF(1791k)] |
| SHEN Xinxin, ZHANG Yihua and HUANG Zhangjian
Research advances in hydrogen sulfide donors
2019,50(3):265. [摘要] [PDF(3924k)] |
| CAI Gongli, CHEN Yu, LIN Shuting, ZHU Dandan, DONG Yiwen, LI Ning and LIU Xiaoxuan
Application of dendrimer-based siRNA delivery systems
2019,50(3):274. [摘要] [PDF(2225k)] |
| YUE Yali, YIN Jun, GAO Xiangdong and YAO Wenbing
Research advances of bispecific antibody drugs in tumor therapy
2019,50(3):289. [摘要] [PDF(2320k)] |
| Original Articles |
| XIN Junbo, LI Fang, LI Ruohan, ZHANG Ran, PAN Furong and MING Xin
Eight-arm polyethylene glycol nanoconjugates for brain targeted delivery of photosensitizer
2019,50(3):299. [摘要] [PDF(4466k)] |
| LIN Xia#, LI Na#, LI Jinwei, YANG Ziyi and JIN Jian
Preparation and evaluation of an oral insulin enteric preparation based on polymer-lipid hybrid nanoparticles
2019,50(3):308. [摘要] [PDF(1247k)] |
| AN Jiong, LI Kan, XU Xiaoming, GAO Zhun, HU Chao, LI Bo, DI Bin and XU Lili
Development and validation of a novel and simple RP-HPLC method for the determination of related substances of tiopronin for injection
2019,50(3):317. [摘要] [PDF(1642k)] |
| LUAN Baolei, XU Xinjun, LIANG Guiting, YOU Mengmeng and LIU Guozhu
Determination of related genotoxic impurities in olmesartan medoxomil by HPLC-MS
2019,50(3):325. [摘要] [PDF(929k)] |
| WANG Yingxin, LIU Ling, LI Shuying, LAN Yi and NIE Lei
Analysis of related substances in montelukast sodium granules by HPLC-MS/MS
2019,50(3):330. [摘要] [PDF(1516k)] |
| GU Yufeng, PAN Xiuxiu, SONG Ling, YANG Xing, HU Liang and LIU Wentao
Experimental study of metformin in relieving bone cancer pain by inhibiting JNK and improving gap junction function
2019,50(3):337. [摘要] [PDF(4008k)] |
| XU Manli, WANG Chang, WANG Nan, HE Hongpeng, ZHANG Tongcun and LUO Xuegang
MALAT1 upregulates SMYD3 by competition with miR-124 and promotes proliferation and migration of breast cancer cells
2019,50(3):344. [摘要] [PDF(2656k)] |
| ZHANG Fan, TIAN Hong and YAO Wenbing
Establishment of a high-throughput analysis method for the identification of key proteases of peptide drugs in vitro
2019,50(3):352. [摘要] [PDF(920k)] |
| Reviews |
| CHENG Weihua#, GUO Feihu#, DENG Xuesong, QIN Xiangyu, FAN Hongqiang and HU Ji
Research progress of synthetic methods of ［18F］F-DOPA
2019,50(3):357. [摘要] [PDF(1017k)] |
| Monograph |
| ZHAO Dongmei, FANG Changjin and QIU Zhixia
Patent analysis for coagulation factor Xa inhibitors
2019,50(3):364. [摘要] [PDF(4055k)] |
| SUN Chuanliang and SUN Libing
IncoPat-based patent analysis of China Pharmaceutical University
2019,50(3):374. [摘要] [PDF(1344k)] |
